These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 29115399)

  • 21. [Circadian variation of clock gene Per2 and cancer-related clock-controlled genes in buccal mucosa carcinoma of golden hamster at different cancer stages].
    Ye H; Yang K; Tan X; Zhao D; Lü X; Wang Q
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2015 Oct; 33(5):513-8. PubMed ID: 26688947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
    Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
    Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
    Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
    Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
    Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
    Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association between miR-499a polymorphism and oral squamous cell carcinoma progression.
    Hou YY; Lee JH; Chen HC; Yang CM; Huang SJ; Liou HH; Chi CC; Tsai KW; Ger LP
    Oral Dis; 2015 Mar; 21(2):195-206. PubMed ID: 24690080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predominant Rab-GTPase amplicons contributing to oral squamous cell carcinoma progression to metastasis.
    da Silva SD; Marchi FA; Xu B; Bijian K; Alobaid F; Mlynarek A; Rogatto SR; Hier M; Kowalski LP; Alaoui-Jamali MA
    Oncotarget; 2015 Sep; 6(26):21950-63. PubMed ID: 26110570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin-like growth factor-independent insulin-like growth factor binding protein 3 promotes cell migration and lymph node metastasis of oral squamous cell carcinoma cells by requirement of integrin β1.
    Yen YC; Hsiao JR; Jiang SS; Chang JS; Wang SH; Shen YY; Chen CH; Chang IS; Chang JY; Chen YW
    Oncotarget; 2015 Dec; 6(39):41837-55. PubMed ID: 26540630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
    Cai Z; Hao XY; Liu FX
    Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterotrimeric G-protein alpha-12 (Gα12) subunit promotes oral cancer metastasis.
    Gan CP; Patel V; Mikelis CM; Zain RB; Molinolo AA; Abraham MT; Teo SH; Abdul Rahman ZA; Gutkind JS; Cheong SC
    Oncotarget; 2014 Oct; 5(20):9626-40. PubMed ID: 25275299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of hyaluronan mediated motility receptor gene in oral squamous cell carcinoma and clinical prognosis.
    Tang Y; Xiao Y; Liao R
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1315-1324. PubMed ID: 35232899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased SEC14L2 expression is associated with clinicopathological features and worse prognosis in oral squamous cell carcinoma.
    David JJ; Kannan B; Pandi C; Jayaseelan VP; Vasagam JM; Arumugam P
    Odontology; 2024 Oct; 112(4):1326-1334. PubMed ID: 38575815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutational analysis of PTEN/PIK3CA/AKT pathway in oral squamous cell carcinoma.
    Cohen Y; Goldenberg-Cohen N; Shalmon B; Shani T; Oren S; Amariglio N; Dratviman-Storobinsky O; Shnaiderman-Shapiro A; Yahalom R; Kaplan I; Hirshberg A
    Oral Oncol; 2011 Oct; 47(10):946-50. PubMed ID: 21824802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated VEGFA mRNA levels in oral squamous cell carcinomas and tumor margins: a preliminary study.
    Sales CB; Buim ME; de Souza RO; de Faro Valverde L; Mathias Machado MC; Reis MG; Soares FA; Ramos EA; Gurgel Rocha CA
    J Oral Pathol Med; 2016 Aug; 45(7):481-5. PubMed ID: 26861159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ZEB1 as an indicator of tumor recurrence for areca quid chewing-associated oral squamous cell carcinomas.
    Ho CM; Hu FW; Lee SS; Shieh TM; Yu CH; Lin SS; Yu CC
    J Oral Pathol Med; 2015 Oct; 44(9):693-8. PubMed ID: 25367287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-211 Enhances the Oncogenicity of Carcinogen-Induced Oral Carcinoma by Repressing TCF12 and Increasing Antioxidant Activity.
    Chen YF; Yang CC; Kao SY; Liu CJ; Lin SC; Chang KW
    Cancer Res; 2016 Aug; 76(16):4872-86. PubMed ID: 27221705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of methylation patterns and expression profiles of p14ARF gene in patients with oral squamous cell carcinoma.
    Kordi-Tamandani DM; Moazeni-Roodi A; Rigi Ladez MA; Hashemi M; Birjandian E; Torkamanzehi A
    Int J Biol Markers; 2010; 25(2):99-103. PubMed ID: 20586029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin-like growth factor-II mRNA binding protein-3 and podoplanin expression are associated with bone invasion and prognosis in oral squamous cell carcinoma.
    Hwang YS; Ahn SY; Moon S; Zheng Z; Cha IH; Kim J; Zhang X
    Arch Oral Biol; 2016 Sep; 69():25-32. PubMed ID: 27232357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PER2 binding to PDK1 enhances the cisplatin sensitivity of oral squamous cell carcinoma through inhibition of the AKT/mTOR pathway.
    Zheng H; Yu W; Ren J; Tang H; Li H; Zhang Z; Yin S; Yang K
    Cell Signal; 2024 Oct; 122():111327. PubMed ID: 39079621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The expression and functional role of a FOXC1 related mRNA-lncRNA pair in oral squamous cell carcinoma.
    Kong XP; Yao J; Luo W; Feng FK; Ma JT; Ren YP; Wang DL; Bu RF
    Mol Cell Biochem; 2014 Sep; 394(1-2):177-86. PubMed ID: 24889262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
    Su L; Wang Y; Xiao M; Lin Y; Yu L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.